Connect with us

MJ Stocks

MedMen Enterprises Inc (OTCMKTS: MMNFF) Aiming High as Fundamentals Remain Strong

Published

on

MedMen Enterprises

The smartest financial decision any investor can make right now is probably investing in the cannabis market. However, you should only be investing in one of the best stocks to realize the best side of the ever-growing industry.

MedMen Enterprises Inc (OTCMKTS: MMNFF) is one that’s showing signs of not stopping, and despite some negative vibes (like most stocks have), the company still boasts strong fundamentals.

MedMen Enterprises Inc. and its subsidiaries is a cannabis company that operates in the US. It cultivates and produces alongside distributing recreational and medical cannabis with the company being strong in California.

Med Men Enterprises Stock Price Analysis

Over the past few years, the company has kept on striving fine to achieve significant milestones to pursue growth opportunities in the United States cannabis market. However, even with the efforts, it’s putting in, the stock has been edging even lower.

The cannabis market is trending higher, and it won’t surprise anyone if the stock’s price gets on the upward trajectory, especially now that the company looks to be doing everything right.

MMNFF price today.

The stock experienced an all-time low to $2.35, but a bounce back to over $2.70 level is needed to turn it bullish as well as aim a breakout at above $3.60 resistance level. Currently, the stocks’ price is at $2.39 and might head rapidly towards high numbers anytime sooner than many out there might be expecting.

MedMens’ Journey

MedMen is one of the best with the largest retail networks as it opened several retail stores in the most significant markets like New York, Las Vegas, and Los Angeles.

How has MedMen performed so far?

The company has thus far had its ups and downs, but what encourages most investors is the fact that it has not lost its course. In terms of year-to-date, the stock has gone down almost by 1.82% whereas that of the S&P gaining 15.96%.

Moreover, the preliminary results for the stock’s fiscal 2019 Q3 were very much encouraging. Across its operations in New York, Nevada, Illinois, Arizona, and California, the total revenue was $36.6 million which was a 22% quarter-over-quarter increase from the fiscal 2019 Q2.

MedMen Recent Development

The company continues to expand its retail network in the cannabis industry even though the stock hasn’t performed to the expectations. The 11th store that the company opened in California (not too long ago) enables the stock to target a broader market.

The store aids the company to push for the market share in the grand $11 billion cannabis market in California.

Subsequently, the company received a boost with a $250 million credit line financing deal they closed with Gotham Green Partners. The agreement is meant to fund the operationalizing the existing retail licenses.

Also, last month, the company acquired licensed marijuana retailer Sugarleaf trading that it a third retail store in the Northern California high-demand market.

Furthermore, the $682 million deal that the company acquires with the private company PharmaCann will help it boost its operational plans. The deal was perhaps the largest in the US marijuana industry which will help MedMen become the largest publicly-traded cannabis company it the US.

Also, there’s room for expansion as several states look to legalize recreational weed. Meanwhile, the partnership within Canada with Cronos Group, forged through a reverse takeover would allow the stock to open the company’s branded locations to the north.

Last year, the company acquired a nursery as well as a retail license which were to aid in building over 35 stores in Florida where pot is growing at a fast pace.

What is Next for MedMen?

All of these moves are strategic, and they set a momentum for the company’s future growth despite all the ups and downs that it has experienced. With its strong branding and well positioning, MedMen is poised for an exciting future.

For the latest updates on MMNFF and the hottest MJ stocks, sign up below!

Disclosure: We have no position in MMNFF and have not been compensated for this article.

Photo by Marius Venter from Pexels

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

MJ Stocks

Is Neptune Wellness Solutions Inc (TSE:NEPT)(NASDAQ:NEPT) A Good Bet Right Now?

Published

on

Neptune Wellness Solutions

There is no doubt 2019 was a tough year for the hemp/cannabis businesses. However, there are a few hemp/cannabis stocks that still managed to make their investors proud. Neptune Wellness Solutions Inc (TSE:NEPT)(NASDAQ:NEPT) is one of those stocks. Investors who put their bet on Neptune at a time like this saw their investment increase 130% by July of last year.

Neptune Wellness Solutions is already off to a strong start in 2020. The stock has gained more than 15% in the past week alone. Looking at how Neptune has positioned itself in the hemp/cannabis market, you cannot dispute 2020 is shaping up to be a great year for the stock. Then you notice that Neptune insiders are deeply invested in the stock. Insiders own more than 17% of all shares in the company. The company’s market cap of $280 million shows that insiders alone have sunk $48 million in the stock.

You are about to find out more reasons why Neptune Wellness Solutions looks to be a good pick right now. But first, here’s what you should know about the company we’re discussing.

About Neptune Wellness Solutions

Neptune Wellness Solutions has been around since 1998 and is headquartered in Laval, Canada. It is engaged in the extraction, formulation, and packaging of value-added cannabis products for both Canadian and global markets.

This is shaping up to be Neptune’s year for a number of…

Continue Reading

MJ Stocks

Is Tetra Bio-Pharma (CVE:TBP) (OTCMKTS:TBPMF) A Smart Pick?

Published

on

Tetra Bio-Pharma

Investors will remember that 2019 wasn’t a great year for cannabis stocks, especially Canadian stocks. Issues from uncertainty over Canada’s national elections to shortage of cannabis retail stores in Ontario greatly weighed on Canadian cannabis stocks last year. These problems are largely out of the way and investors can now spot cannabis stocks with a promising outlook in 2020. Tetra Bio-Pharma (CVE:TBP) (OTCMKTS:TBPMF) is one play poised for a big breakout in 2020 as its drug products go on sale.

Tetra Bio-Pharma is one of the most promising cannabis stocks in 2020 and investors have really warmed up to the stock. At $0.50, Tetra stock has already gained more than 60% year-to-date. But that is just the beginning and we feel there is a great story to tell here. First, however, it is important for investors to understand the company we’re discussing.

About Tetra Bio-Pharma

For investors who may have just come across Tetra Bio-Pharma for the very first time, this is a Canadian cannabis company. It is focused on developing cannabis-based drugs for a variety of conditions, including cancer.

Tetra Bio-Pharma about to begin commercializing its drug products

As a drug company, Tetra Bio-Pharma is insulated from many challenges that face conventional cannabis companies. For example, companies that make adult-use cannabis products must cope with cutthroat competition in the market. Moreover, Canadian cannabis companies have Continue Reading

MJ Stocks

Why Investors Are Warming Up To Fire & Flower Holdings Corp (TSE:FAF) (OTCMKTS:FFLWF)

Published

on

Fire & Flower Holdings

The disastrous 2019 taught investors the importance of carefully screening cannabis stocks for great picks that can withstand industrywide shocks. That explains why investors are warming up to Fire & Flower Holdings Corp (TSE:FAF) (OTCMKTS:FFLWF) in 2020.

Fire & Flower Holdings has positioned itself to take full advantage of the recently expanded cannabis market under Cannabis 2.0. Investors are realizing that FFLWF is one pick that can make a huge difference in their cannabis portfolio. Fire & Flower Holdings has already gained more than 25% year-to-date, a testament to the strong investor interest in the stock in 2020.

About Fire & Flower Holdings

Fire & Flower Holdings is a Canadian cannabis company. It operates as a cannabis product retail chain. It operates a network of dozens of cannabis retail outlets in Canada. FFLWF currently has licenses to operate cannabis retail stores in Alberta and Saskatchewan provinces. In addition, it runs a cannabis distributor business in Saskatchewan.

Investors will no doubt remember that 2019 was a tough year for the cannabis sector, with a widespread collapse of many cannabis stocks big and small. That shows why in 2020 investors are looking for cannabis stocks that can deliver excellent returns and make them forget the pain of the past year. FFLWF has emerged as one of the favorite cannabis stock picks for investors early on in 2020. There are several reasons behind that and here are…

Continue Reading

MJ Stocks